ICS-containing inhalers are commonly prescribed to patients after acute respiratory tract infections, often without diagnostic evaluation.
Low-dose ICS remain essential for every asthma patient, and GINA/CFA guidance favors phenotype-tailored step-up strategies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results